Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A global partnership agreement with Eckuity Capital to develop next-generation technology infrastructure-built on strong ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by "la Caixa" Foundation, in collaboration with the Clínic-IDIBAPS, has shown for the first time, how lung ...

Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet ...

A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

The global COPD therapeutics market is on a robust growth trajectory, having achieved a market valuation of USD 12,144.1 million in 2023, and is projected to reach USD 20,035.5 million by 2033, ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD ...

The global breath analyzer market Key growth drivers include stringent drunk-driving regulations, technological advancements, and increasing adoption ...